285 related articles for article (PubMed ID: 30772369)
1. Parkinson's disease and pain: Modulation of nociceptive circuitry in a rat model of nigrostriatal lesion.
Domenici RA; Campos ACP; Maciel ST; Berzuino MB; Hernandes MS; Fonoff ET; Pagano RL
Exp Neurol; 2019 May; 315():72-81. PubMed ID: 30772369
[TBL] [Abstract][Full Text] [Related]
2. Monoaminergic regulation of nociceptive circuitry in a Parkinson's disease rat model.
Campos ACP; Berzuino MB; Hernandes MS; Fonoff ET; Pagano RL
Exp Neurol; 2019 Aug; 318():12-21. PubMed ID: 31028827
[TBL] [Abstract][Full Text] [Related]
3. Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia.
Dieb W; Ouachikh O; Durif F; Hafidi A
Brain Behav; 2014 May; 4(3):368-80. PubMed ID: 24944866
[TBL] [Abstract][Full Text] [Related]
4. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions.
Bagga V; Dunnett SB; Fricker RA
Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616
[TBL] [Abstract][Full Text] [Related]
5. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat.
Afshin-Majd S; Bashiri K; Kiasalari Z; Baluchnejadmojarad T; Sedaghat R; Roghani M
Biomed Pharmacother; 2017 May; 89():1-9. PubMed ID: 28199883
[TBL] [Abstract][Full Text] [Related]
7. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
8. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
9. Motor Cortex Stimulation Reversed Hypernociception, Increased Serotonin in Raphe Neurons, and Caused Inhibition of Spinal Astrocytes in a Parkinson's Disease Rat Model.
Campos ACP; Berzuíno MB; Barbosa GR; Freire HMRC; Lopes PS; Assis DV; Fonoff ET; Pagano RL
Cells; 2021 May; 10(5):. PubMed ID: 34064617
[TBL] [Abstract][Full Text] [Related]
10. Nociceptive Response to L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.
Nascimento GC; Bariotto-Dos-Santos K; Leite-Panissi CRA; Del-Bel EA; Bortolanza M
Neurotox Res; 2018 Nov; 34(4):799-807. PubMed ID: 29611150
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
12. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
Winkler C; Kirik D; Björklund A; Cenci MA
Neurobiol Dis; 2002 Jul; 10(2):165-86. PubMed ID: 12127155
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease.
Kamińska K; Lenda T; Konieczny J; Wardas J; Lorenc-Koci E
Neurochem Int; 2018 Dec; 121():125-139. PubMed ID: 30290201
[TBL] [Abstract][Full Text] [Related]
14. Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response.
Mendes-Pinheiro B; Soares-Cunha C; Marote A; Loureiro-Campos E; Campos J; Barata-Antunes S; Monteiro-Fernandes D; Santos D; Duarte-Silva S; Pinto L; José Salgado A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768962
[TBL] [Abstract][Full Text] [Related]
15. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
Levandis G; Balestra B; Siani F; Rizzo V; Ghezzi C; Ambrosi G; Cerri S; Bonizzi A; Vicini R; Vairetti M; Ferrigno A; Pastoris O; Blandini F
Neurogastroenterol Motil; 2015 Dec; 27(12):1783-95. PubMed ID: 26433214
[TBL] [Abstract][Full Text] [Related]
16. Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model.
Miyanishi K; Choudhury ME; Watanabe M; Kubo M; Nomoto M; Yano H; Tanaka J
Neurochem Int; 2019 Jan; 122():38-46. PubMed ID: 30419255
[TBL] [Abstract][Full Text] [Related]
17. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
[TBL] [Abstract][Full Text] [Related]
18. Exercise protects synaptic density in a rat model of Parkinson's disease.
Binda KH; Lillethorup TP; Real CC; Bærentzen SL; Nielsen MN; Orlowski D; Brooks DJ; Chacur M; Landau AM
Exp Neurol; 2021 Aug; 342():113741. PubMed ID: 33965411
[TBL] [Abstract][Full Text] [Related]
19. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.
Palmer MR; Granholm AC; van Horne CG; Giardina KE; Freund RK; Moorhead JW; Gerhardt GA
Brain Res; 2001 Jan; 890(1):86-99. PubMed ID: 11164771
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
